Indirect costs of cervical and breast cancers in Spain

European Journal of Health Economics

Volumn 6, Issue 4, 2005, Pages 309-313

  Oliva, Juan ^c   Lobo, Félix ^d   López Bastida, Julio ^a   Zozaya, Néboa ^d   Romay, Rosa ^b  

^a Canary Islands Health Service   (Spain)

^b Regional Health Council   (Spain)

^c UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^d NONE

Author keywords

Cancer; Friction cost; Human capital; Indirect costs; Spain

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CAPITAL; CHILD; COST; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN; PHYSICAL DISABILITY; PRIORITY JOURNAL; PRODUCTIVITY; SPAIN; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; COST OF ILLNESS; DISABILITY EVALUATION; EFFICIENCY; EMPLOYMENT; FEMALE; HEALTH PRIORITIES; HUMANS; MIDDLE AGED; REGISTRIES; SPAIN; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

EID: 28844507935     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-005-0303-4     Document Type: Article

References (35)

1. American Cancer Society (2001) Cancer facts and figures 2001. American Cancer Society: Atlanta. Available at: www.cancer.org (accessed 3 March 2004)
2. Becker GS (1994) Human capital, 3rd edn. University of Chicago Press: Chicago
3. Boer R, de Koning HJ, van Oortmarssen GJ, van der Maas PJ (1995) In search of the best upper age limit for breast cancer screening. Eur J Cancer 31A:2040-2043
4. Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, Woodman C (1998) Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ 317:376-379
5. Borghouts JA, Koes BW, Vondeling H, Bouter LM (1999) Cost-of-illness of neck pain in The Netherlands in 1996. Pain 80:629-636
6. Canadian Coordinating Office for Health Technology Assessment (CCOHTA) (1997) Guidelines for economic evaluation of pharmaceutical, 2nd edn. CCOHTA: Ottawa
7. Grossman M (1972) The demand for health: a theoretical and empirical investigation. Columbia University Press: New York
8. Grossman M (2000) The human capital model of the demand for health. In: Culyer AJ, Newhouse JP (eds) Handbook of health economics. North-Holland: Amsterdam
9. Gyrd-Hansen D, Holund B, Andersen P (1995) A cost-effectivenes analysis of cervical cancer screening: health policy implications. Health Policy 34:35-51
10. Hodgson TA, Meiners MR (1982) Cost-of-illness methodology: a guide to assessment practices and procedures. Milbank Q 60:429-491
11. Hutubessy RC, van Tulder MW, Vondeling H, Bouter LM (1999) Indirect costs of back pain in The Netherlands: a comparison of the human capital method with the friction cost method. Pain 80:201-207
12. Instituto Nacional de Estadistica (INE) (2000). Registro de Defunciones por Causa de Muerte. Available at: http://www.ine.es/inebase/menu2.htm8 (accessed 3 March 2004)
13. Instituto Nacional de Estadística (INE) (2000) Encuesta de Salarios en la Industria y los Servicios. Available at: http://www.ine.es/ inebase/menu2.htm8 (accessed 3 March 2004)
14. Instituto Nacional de Estadistica (INE) (2000) Encuesta de Población Activa. Available at: http://www.ine.es/inebase/menu2.htm8 (accessed 3 March 2004)
15. Johannesson M, Karlsson G (1997) The friction cost method: a comment. J Health Econ 16:249-255
16. Johansson PO (1995) Evaluating health risks: an economic approach. Cambridge University Press: Cambridge
17. Johnson-Thompson MC, Guthrie J (2000) Ongoing research to identify environmental risk factors in breast carcinoma. Cancer 88 [Suppl 5]:1224-1229
18. Koopmanschap MA, van Ineveld BM (1992)Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34:1005-1010
19. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L (1995) The friction cost method for measuring indirect cost of disease. J Health Econ 14:171-189
20. Leivo T, Sintonen H, Tuominen R, Hakama M, Pukkala E, Heinonen OP (1999) The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992. Cancer 86:638-646
21. Liljas B (1998) How to calculate indirect costs in economic evaluation. Pharmacoeconomics 13:1-7
22. Lofland JH, Locklear JC, Frick KD (2001) Different approaches to valuing the lost productivity of patients with migraine. Pharmacoeconomics 19:917-925
23. López-Abente G et al., unpublished
24. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang Y et al. (2002) Benefits and cost of using HPV testing to screen for cervical cancer. JAMA 287:2372-2381
25. Marcotte DE, Wilcox-Gok V (2001) Estimating the employment and earnings costs of mental illness: recent developments in the United States. Soc Sci Med 53:21-27
26. Max W, Rice DP, Mackenzie EJ (1990) The lifetime cost of injury. Inquiry 27:332-343
27. Max W, Rice DP, Sung HY, Michel M, Breuer W, Zhang X (2003) The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol 88:96-103
28. Mettlin C (1999) Global breast cancer mortality statistics. CA Cancer J Clin 49:138-144
29. Ministerio de Sanidad y Consumo (2003) Plan integral de la cardiopatía isquémica en España. Available at: http://www.msc.es/Diseno/planesIntegrales/planes_integrales.htm (accessed 3 March 2004)
30. Mishan EJ (1990) Cost-benefit analysis: an informal introduction, 4th edn. Unwin Hyman: London
31. Oliva J, Lobo F, López-Bastida J, Duque B, Osuna R (2004) Costes no sanitarios ocasionados por las enfermedades isquémicas del corazón en España. Cuadernos Econ ICE 67:263-298
32. Olsen JA, Smith RD (2001) Theory versus practice: a review of 'willingness-to-pay' in health and health care. Health Econ 10:39-52
33. Robinson JC (1986) Philosophical origins of the economic valuation of life. Milbank Q 64:133-155
34. Thorn TJ (1996) Economic costs of neoplasms, arteriosclerosis, and diabetes in United States. In Vivo 10:255-260
35. Tyczynski JE, Bray F, Parkin DM (2002) Breast cancer in Europe. ENCR Cancer Fact Sheets vol 2. Available at: http://www.encr.com.fr/ENCR13.htm (accessed 3 March 2004)